Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases
Description
Disease-modifying therapies (DMTs) are widely used in neuroimmunological diseases such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Although these treatments are known to predispose patients to infections and affect